References
- US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 2000; 54:1166–75.
- Scammell TE, Estabrooke W, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. Journal of Neuroscience 2000;20:8620–8.
- Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. Journal of Neurology, Neurosurgery and Psychiatry 2002;72:179–83.
- Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, Thompson M, Mack II. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. Journal of Sleep Research 1995;4:212–28.
- Kraus MF. Neuropsychiatric sequelae of stroke and traumatic brain injury: the role of psychostimulants. International Journal of Psychiatry in Medicine 1995;25:39–51.
- Teitelman E. Off-label uses of modafinil. American Journal of Psychiatry 2001;158:1341.
- Schwartz JR, Feldman NT, Bogan RK. Dosing-regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clinical Neuropharmacology 2003; 26:252–7.